Zygomycosis in a Tertiary‐Care Cancer Center in the Era ofAspergillus‐Active Antifungal Therapy: A Case‐Control Observational Study of 27 Recent Cases | Zendy

Dimitrios P. Kontoyiannis | Zendy; Michail S. Lionakis | Zendy; Russell E. Lewis | Zendy; Georgios Chamilos | Zendy; Mimi Healy | Zendy; C Perego | Zendy; Amar Safdar | Zendy; Hagop M. Kantarjian | Zendy; Richard E. Champlin | Zendy; Thomas J. Walsh | Zendy; Issam Raad | Zendy

Open Access

Zygomycosis in a Tertiary‐Care Cancer Center in the Era ofAspergillus‐Active Antifungal Therapy: A Case‐Control Observational Study of 27 Recent Cases

Author(s) -

Dimitrios P. Kontoyiannis,

Michail S. Lionakis,

Russell E. Lewis,

Georgios Chamilos,

Mimi Healy,

C Perego,

Amar Safdar,

Hagop M. Kantarjian,

Richard E. Champlin,

Thomas J. Walsh,

Issam Raad

Publication year - 2005

Publication title -

the journal of infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.69

H-Index - 252

eISSN - 1537-6613

pISSN - 0022-1899

DOI - 10.1086/428780

Subject(s) - zygomycosis , voriconazole , antifungal , tertiary care , medicine , observational study , aspergillosis , intensive care medicine , mycosis , cancer , amphotericin b , surgery , dermatology , immunology

Anecdotal evidence suggests a rise in zygomycosis in association with voriconazole (VRC) use in immunosuppressed patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research